Low Molecular Weight Heparin vs Direct Oral Anticoagulant After Bariatric Surgery

Phase 1Active Not RecruitingNCT06913595

Cairo University100 enrolled

Overview

Extended Venous Thromboemboism Prophylaxis After Bariatric Surgeries: A Comparison Of Low Molecular Weight Heparin With Direct Oral Anticoagulant

This study aims to compare the effectiveness of rivaroxaban versus low molecular weight heparin in reducing the incidence of PMVT after bariatric surgery.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

100

Conditions

Deep Venous Thrombosis

Interventions

Direct Oral Anticoagulant.DRUG

Direct Oral Anticoagulant AFTER BARIATRIC SURGERY

Low Molecular Weight HeparineDRUG

Low molecular weight heparin after bariatric surgery

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: \- BARIATRIC PATIENTS Exclusion Criteria: * BLEEDING TENDENCY

Locations (1)

Cairo University

Cairo, Egypt

Outcomes

Primary Outcomes

VENOUS THROMBOEMBOLISM

DVT after bariatric surgery

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.